Consumul regulat de glucozamin\u0103, un supliment popular comercializat\u0103 f\u0103r\u0103 re\u0163et\u0103 \u015fi utilizat pentru durerile articulare, este asociat cu un risc mai mare de evolu\u0163ie de la tulbur\u0103ri cognitive u\u015foare la demen\u0163\u0103, conform unei analize ample care ar putea oferi noi metode de tratament, informeaz\u0103 vineri agen\u021bia de \u0219tiri Reuters, citat\u0103 de Agerpres.<\/p>\n
Analiz\u00e2nd dosarele medicale colectate \u00eentre anii 2012 \u015fi 2024 de la aproape 60.000 de pacien\u0163i cu deficien\u0163\u0103 cognitiv\u0103 \u00een diferite stadii, cercet\u0103torii au descoperit c\u0103 utilizarea regulat\u0103 a glucozaminei era asociat\u0103 cu un risc cu 25% mai mare de progresie de la deficien\u0163\u0103 u\u015foar\u0103 la demen\u0163\u0103.<\/p>\n
\u00cen plus, consumul de glucozamin\u0103 a fost asociat cu o cre\u015ftere cu 25% a riscului de deces pe parcursul studiului \u00een r\u00e2ndul pacien\u0163ilor care sufereau deja de demen\u0163\u0103, se arat\u0103 \u00eentr-un raport publicat \u00een jurnalul \u015ftiin\u0163ific Nature Metabolism.<\/p>\n
\u00cen cazul pacien\u0163ilor care prezentau doar tulbur\u0103ri cognitive u\u015foare, nu a fost observat un astfel de efect, ceea ce sugereaz\u0103 c\u0103 impactul glucozaminei ar putea fi mai mare la pacien\u0163ii cu demen\u0163\u0103 confirmat\u0103, au afirmat cercet\u0103torii.<\/p>\n
\u00cen experimentele realizate pe animale, cercet\u0103torii au descoperit c\u0103 glucozamina exacerbeaz\u0103 un proces d\u0103un\u0103tor din creier numit hiper-glicozilare, \u00een cazul c\u0103ruia ata\u015farea anormal\u0103 a moleculelor de zaharuri la proteinele din creier perturb\u0103 func\u0163iile neurologice critice.<\/p>\n
\u201eDatele din dosarele medicale electronice sunt extrem de provocatoare\u201d, a declarat coautorul studiului, Matt Gentry, de la Universitatea din Florida, citat \u00eentr-un comunicat.<\/p>\n
\u201eDe\u015fi este vorba despre o asociere \u015fi nu despre o dovad\u0103 a cauzalit\u0103\u0163ii, se ridic\u0103 o problem\u0103 clinic\u0103 important\u0103, ce merit\u0103 acum mult mai mult\u0103 aten\u0163ie\u201d, a ad\u0103ugat cercet\u0103torul.<\/p>\n
Un comentariu publicat \u00eempreun\u0103 cu studiul afirm\u0103 c\u0103 agravarea demen\u0163ei asociat\u0103 cu glicozilarea crescut\u0103 asociat\u0103 cu glucozamina din alimenta\u0163ie sugereaz\u0103 c\u0103 aceast\u0103 reac\u0163ie chimic\u0103 poate fi vizat\u0103 \u00een procesul de c\u0103utare a unei modalit\u0103\u0163i de combatere a acestei boli.<\/p>\n","protected":false},"excerpt":{"rendered":"Consumul regulat de glucozamin\u0103, un supliment popular comercializat\u0103 f\u0103r\u0103 re\u0163et\u0103 \u015fi utilizat pentru durerile articulare, este asociat cu…\n","protected":false},"author":2,"featured_media":203811,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[12],"tags":[32,33,31,18611,36,37,57507,27,74,34,35,25,41,40,38,39,26,28,29,30,71,72,73],"class_list":["post-203810","post","type-post","status-publish","format-standard","has-post-thumbnail","category-international","tag-breaking-news","tag-breakingnews","tag-cele-mai-populare-subiecte","tag-dementa","tag-featured-news","tag-featurednews","tag-glucozamina","tag-headlines","tag-international","tag-latest-news","tag-latestnews","tag-news","tag-ro","tag-romana","tag-romania","tag-romanian","tag-stiri","tag-titluri","tag-top-stories","tag-topstories","tag-world","tag-world-news","tag-worldnews"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ro\/116738642927438941","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/posts\/203810","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/comments?post=203810"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/posts\/203810\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/media\/203811"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/media?parent=203810"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/categories?post=203810"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/tags?post=203810"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}